- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Survey Finds Depression, Anxiety Common in Patients With Atopic Dermatitis
Sponsors of the survey want to draw attention to the mental health aspects of living with condition, which causes the immune system to overreact.
More than 30% of adults with atopic dermatitis report having a diagnosis of depression and/or anxiety, according to survey results reported Thursday by the National Eczema Association.
The results are based on survey of 545 people with atopic dermatitis, a type of eczema caused by an overactive immune system. People with this condition have a leaky outer layer of skin that allows irritants and allergens to pass through, triggering the immune system and causing inflammation.
The result is an itchy, red rash that can leak fluid and create thickened, cracked skin. It affects about 15 million people in the United States.
These findings indicate the number of people with atopic dermatitis living with depression is 4 times higher than the general population, which is estimated by CDC to be 7.6%.
“Atopic dermatitis is a complex disease, as this survey shows,” Julie Block, president and CEO of the National Eczema Association, said in a statement. “Research reveals this form of eczema goes well beyond what you see on the skin. Chronic inflammation, symptoms such as unbearable itch, being severely allergic to the world around you—these profoundly affect the quality of life for people with AD [atopic dermatitis].”
The group is raising awareness about the mental health effects of atopic dermatitis during the month of October, which is Eczema Awareness Month, Block said. “In honor of Eczema Awareness Month and in recognition of the challenges people with eczema face, we’ve gathered information on our site from experts on mental health and chronic disease,” says Block. “Visitors will find the range of resources to help them understand and manage the emotional ups and downs of eczema.”
To further raise awareness about mental health issues with the condition, the National Eczema Association will be hosting a Facebook Live chat with the Organization for Advancement and Integration in Medical Sciences, or naims.org, which encourages multidisciplinary research across medical specialties.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More
